Filing Details

Accession Number:
0001437749-20-011877
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-27 21:54:27
Reporting Period:
2020-05-22
Accepted Time:
2020-05-27 21:54:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
946486 Windtree Therapeutics Inc WINT Biological Products, (No Disgnostic Substances) (2836) 943171943
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1624401 Steven Simonson 2600 Kelly Road
Suite 100
Warrington PA 18976
Svp, Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-22 517 $7.25 10,802 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants Acquisiton 2020-05-22 517 $0.00 517 $7.98
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
517 2020-05-22 2025-05-22 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 292 Indirect By Trust
Footnotes
  1. Adjusted to reflect 1-for-3 reverse stock split effective April 29, 2020.
  2. Holding amount represents issuer's matching stock contribution pursuant to 401(k) plan.
  3. Issued in connection with the purchase of shares of common stock on May 22, 2020 as reported above.